Literature DB >> 25692204

Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014.

Chantal Reusken, Matthias Niedrig, Suzan Pas, Pedro Anda, Sylvain Baize, Remi Charrel, Antonino Di Caro, Christian Drosten, Maria Dolores Fernandez-Garcia, Leticia Franco, Stephan Gunther, Isabelle Leparc-Goffart, Byron Martina, Delphine Pannetier, Anna Papa, Maria Paz Sanchez-Seco, Olli Vapalahti, Marion Koopmans.   

Abstract

On August 8 2014, the World Health Organization (WHO) declared the outbreak of Ebola Virus Disease (EVD) evolving in West Africa since December 2013, a Public Health Emergency of International Concern (PHEIC). It is expected that the outbreak of Ebolavirus Disease (EVD) in West Africa will lead to increased testing of individuals in Europe for EVD. The severity of the situation in West Africa warranted a critical appraisal of the laboratory preparedness and response for EVD, with a focus on information needs for laboratories involved in diagnostics of rare viral diseases associated with the European Network for the Diagnostics of "Imported" Viral Diseases", ENIVD. Essential knowledge and knowledge gaps for an adequate laboratory response focusing on virus properties, infection kinetics, tests specifics and field performances were identified. An inventory of the laboratory capacity for EVD diagnostics among ENIVD laboratories was made.

Entities:  

Mesh:

Year:  2015        PMID: 25692204     DOI: 10.1016/j.jcv.2014.11.007

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  14 in total

1.  Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.

Authors:  Sophie J Smither; Simon A Weller; Amanda Phelps; Lin Eastaugh; Sarah Ngugi; Lyn M O'Brien; Jackie Steward; Steve G Lonsdale; Mark S Lever
Journal:  J Clin Microbiol       Date:  2015-07-15       Impact factor: 5.948

Review 2.  Diagnosis of Ebola Virus Disease: Past, Present, and Future.

Authors:  M Jana Broadhurst; Tim J G Brooks; Nira R Pollock
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

Review 3.  The Role of Exosomal VP40 in Ebola Virus Disease.

Authors:  Michelle L Pleet; Catherine DeMarino; Benjamin Lepene; M Javad Aman; Fatah Kashanchi
Journal:  DNA Cell Biol       Date:  2017-02-08       Impact factor: 3.311

4.  Development of Prototype Filovirus Recombinant Antigen Immunoassays.

Authors:  Matt L Boisen; Darin Oottamasathien; Abigail B Jones; Molly M Millett; Diana S Nelson; Zachary A Bornholdt; Marnie L Fusco; Dafna M Abelson; Shun-Ichiro Oda; Jessica N Hartnett; Megan M Rowland; Megan L Heinrich; Marjan Akdag; Augustine Goba; Mambu Momoh; Mohammed Fullah; Francis Baimba; Michael Gbakie; Sadiki Safa; Richard Fonnie; Lansana Kanneh; Robert W Cross; Joan B Geisbert; Thomas W Geisbert; Peter C Kulakosky; Donald S Grant; Jeffery G Shaffer; John S Schieffelin; Russell B Wilson; Erica Ollmann Saphire; Luis M Branco; Robert F Garry; S Humarr Khan; Kelly R Pitts
Journal:  J Infect Dis       Date:  2015-07-30       Impact factor: 5.226

5.  Evaluation of the Biofire FilmArray BioThreat-E Test (v2.5) for Rapid Identification of Ebola Virus Disease in Heat-Treated Blood Samples Obtained in Sierra Leone and the United Kingdom.

Authors:  Simon A Weller; Daniel Bailey; Steven Matthews; Sarah Lumley; Angela Sweed; Derren Ready; Gary Eltringham; Jade Richards; Richard Vipond; Roman Lukaszewski; Phillippa M Payne; Emma Aarons; Andrew J Simpson; Emma J Hutley; Tim Brooks
Journal:  J Clin Microbiol       Date:  2015-11-04       Impact factor: 5.948

6.  Molecular Characterization of the First Ebola Virus Isolated in Italy, from a Health Care Worker Repatriated from Sierra Leone.

Authors:  Concetta Castilletti; Fabrizio Carletti; Cesare E M Gruber; Licia Bordi; Eleonora Lalle; Serena Quartu; Silvia Meschi; Daniele Lapa; Francesca Colavita; Roberta Chiappini; Antonio Mazzarelli; Patrizia Marsella; Nicola Petrosillo; Emanuele Nicastri; Giovanni Chillemi; Alessio Valentini; Alessandro Desideri; Antonino Di Caro; Giuseppe Ippolito; Maria R Capobianchi
Journal:  Genome Announc       Date:  2015-06-18

Review 7.  Virological diagnosis of Ebolavirus infection.

Authors:  D W Smith; W D Rawlinson; J Kok; D E Dwyer; M Catton
Journal:  Pathology       Date:  2015-08       Impact factor: 5.306

8.  External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014 - 2016 Ebola outbreak in West Africa.

Authors:  Heinz Ellerbrok; Sonja Jacobsen; Pranav Patel; Toni Rieger; Markus Eickmann; Stephan Becker; Stephan Günther; Dhamari Naidoo; Livia Schrick; Kathrin Keeren; Angelina Targosz; Anette Teichmann; Pierre Formenty; Matthias Niedrig
Journal:  PLoS Negl Trop Dis       Date:  2017-05-01

9.  Development of Lentivirus-Based Reference Materials for Ebola Virus Nucleic Acid Amplification Technology-Based Assays.

Authors:  Giada Mattiuzzo; James Ashall; Kathryn S Doris; Kirsty MacLellan-Gibson; Carolyn Nicolson; Dianna E Wilkinson; Ruth Harvey; Neil Almond; Robert Anderson; Stacey Efstathiou; Philip D Minor; Mark Page
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

10.  Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus.

Authors:  Benjamin A Pinsky; Malaya K Sahoo; Johanna Sandlund; Marika Kleman; Medha Kulkarni; Per Grufman; Malin Nygren; Robert Kwiatkowski; Ellen Jo Baron; Fred Tenover; Blake Denison; Russell Higuchi; Reuel Van Atta; Neil Reginald Beer; Alda Celena Carrillo; Pejman Naraghi-Arani; Chad E Mire; Charlene Ranadheera; Allen Grolla; Nina Lagerqvist; David H Persing
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.